Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological Advances in the Treatment of Age-related Macular Degeneration
María Gil‐Martínez, Paz Santos-Ramos, María Isabel Fernández, et al.
Current Medicinal Chemistry (2019) Vol. 27, Iss. 4, pp. 583-598
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The Impact of Oxidative Stress on Blood-Retinal Barrier Physiology in Age-Related Macular Degeneration
Annamaria Tisi, Marco Feligioni, M. Passacantando, et al.
Cells (2021) Vol. 10, Iss. 1, pp. 64-64
Open Access | Times Cited: 101
Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems
Kevin Y. Wu, Maxine Joly-Chevrier, Dania Akbar, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1094-1094
Open Access | Times Cited: 21
Causal Effects of Gut Microbiota on Age-Related Macular Degeneration: A Mendelian Randomization Study
Deshen Mao, Borui Tao, Shuyan Sheng, et al.
Investigative Ophthalmology & Visual Science (2023) Vol. 64, Iss. 12, pp. 32-32
Open Access | Times Cited: 17
Non-Coding RNAs Regulating Mitochondrial Functions and the Oxidative Stress Response as Putative Targets against Age-Related Macular Degeneration (AMD)
Juha M. T. Hyttinen, Janusz Błasiak, Kai Kaarniranta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2636-2636
Open Access | Times Cited: 15
Navigating the evolution of ophthalmic drug delivery and ocular regenerative medicine from conventional to cutting-edge treatments
Nadia Mostafavi Nezhad, Maryam Rahimi, Fatemeh Gheybi, et al.
Applied Materials Today (2025) Vol. 42, pp. 102602-102602
Closed Access
Intravitreal anti-VEGF drug delivery systems for age-related macular degeneration
Andrea Luaces-Rodríguez, Cristina Mondelo‐García, Irene Zarra‐Ferro, et al.
International Journal of Pharmaceutics (2019) Vol. 573, pp. 118767-118767
Closed Access | Times Cited: 40
Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration
Eduardo A. Chacin Ruiz, Katelyn E. Swindle‐Reilly, Ashlee N. Ford Versypt
Journal of Controlled Release (2023) Vol. 363, pp. 464-483
Open Access | Times Cited: 12
Serum lipids mediate the association of per- and polyfluoroalkyl substances exposure and age-related macular degeneration
Xiaodong Chen, Jiaqi Li, Ningda Xu, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317678-e0317678
Open Access
Advances in the Study of Age-Related Macular Degeneration Based on Cell or Cell-Biomaterial Scaffolds
Ziming Li, Zhiyong Hu, Zhixian Gao
Bioengineering (2025) Vol. 12, Iss. 3, pp. 278-278
Open Access
Comparative evaluation of four Lycium barbarum cultivars on NaIO3-induced retinal degeneration mice via multivariate statistical analysis
Xin Chen, Dandan Wei, Ming‐Tsan Lin, et al.
Journal of Ethnopharmacology (2024) Vol. 325, pp. 117889-117889
Closed Access | Times Cited: 3
Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
João Estarreja, Priscila Mendes, Carina Silva, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1000-1000
Open Access | Times Cited: 3
The Impact of NF-κB on Inflammatory and Angiogenic Processes in Age-Related Macular Degeneration
Waleed Hassan Almalki, Salem Salman Almujri
Experimental Eye Research (2024) Vol. 248, pp. 110111-110111
Closed Access | Times Cited: 3
Preclinical challenges for developing long acting intravitreal medicines
Sahar Awwad, Christin Henein, Nkiruka Ibeanu, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 153, pp. 130-149
Open Access | Times Cited: 26
Advances in the therapeutic application and pharmacological properties of kinsenoside against inflammation and oxidative stress-induced disorders
Li Lü, Yuan Xiong, Ze Lin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Reliability of Retinal Pathology Quantification in Age-Related Macular Degeneration: Implications for Clinical Trials and Machine Learning Applications
Philipp L. Müller, Bart Liefers, Tim Treis, et al.
Translational Vision Science & Technology (2021) Vol. 10, Iss. 3, pp. 4-4
Open Access | Times Cited: 20
RGD-modified multifunctional nanoparticles encapsulating salvianolic acid A for targeted treatment of choroidal neovascularization
Junxiu Zhang, Jingyi Zhu, Lingzhou Zhao, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 20
The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis
João Estarreja, Priscila Mendes, Carina Silva, et al.
JMIR Research Protocols (2023) Vol. 12, pp. e38658-e38658
Open Access | Times Cited: 7
Recent Advances in Proteomics-Based Approaches to Studying Age-Related Macular Degeneration: A Systematic Review
Laura García‐Quintanilla, Lorena Rodríguez-Martínez, Enrique Bandín‐Vilar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14759-14759
Open Access | Times Cited: 12
Suppression of Age-Related Macular Degeneration-like Pathology by c-Jun N-Terminal Kinase Inhibitor IQ-1S
А. А. Жданкина, D. I. Тikhonov, С. В. Логвинов, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 395-395
Open Access | Times Cited: 6
Degeneration-Dependent Retinal Remodeling: Looking for the Molecular Trigger
Michael Telias, Scott Nawy, Richard Krämer
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 15
Treatment outcomes of injectable thermosensitive hydrogel containing bevacizumab in intervertebral disc degeneration
Qian Chen, Juehan Wang, Qinghong Xia, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 9
Identification of Diagnostic Biomarkers and Their Correlation with Immune Infiltration in Age-Related Macular Degeneration
Yuyang Zeng, Xiujuan Yin, Changzheng Chen, et al.
Diagnostics (2021) Vol. 11, Iss. 6, pp. 1079-1079
Open Access | Times Cited: 9
Metallothioneins, a Part of the Retinal Endogenous Protective System in Various Ocular Diseases
Daniel Jamrozik, Radosław Dutczak, Joanna Machowicz, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1251-1251
Open Access | Times Cited: 3
Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration
Laura García‐Quintanilla, Pablo Almuiña-Varela, Olalla Maroñas, et al.
Investigative Ophthalmology & Visual Science (2023) Vol. 64, Iss. 13, pp. 34-34
Open Access | Times Cited: 3
Exploration of the Specific Pathology of HXMM Tablet Against Retinal Injury Based on Drug Attack Model to Network Robustness
Yujie Xi, Yan Miao, Rui Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top